StageZero Life Sciences Ltd - Company Profile
Powered by 
All the data and insights you need on StageZero Life Sciences Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date StageZero Life Sciences Ltd Strategy Report
- Understand StageZero Life Sciences Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
StageZero Life Sciences Ltd (StageZero Life Sciences) is a provider of molecular diagnostic solutions. The company utilizes a telehealth program that uses advanced diagnostics for the detection of cancer and chronic diseases at early stages. StageZero Life Sciences has developed blood-based biomarker tests to identify colorectal cancer. The company’s Sentinel Principle technology is used in early diagnosis, determining the stage of disease, identifying responders and monitoring treatment compliance, among others. It also provides Aristotle, an mRNA-based test that detects multiple cancers from a single sample of blood. The company conducts screening tests for colon cancer, lung cancer, prostate cancer, breast cancer, among others. StageZero Life Sciences is headquartered in Richmond Hill, Ontario, Canada.
Headquarters
Canada
Address
30-70 East Beaver Creek Road, Richmond Hill, Ontario, L4B3B2
Website
www.stagezerolifesciences.com
Telephone
1 905 2092030
No of Employees
40
Industry
Medical Equipment
Ticker Symbol & Exchange
SZLS (TSE)
Revenue (2022)
$3.8M
-25.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-52.5%
(2022 vs 2021)
Market Cap*
$3.6M
Net Profit Margin (2022)
XYZ
-103.7%
(2022 vs 2021)
* As of and is in US$
StageZero Life Sciences Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Aristotle Blood Test | Sentinel Principle |
| Sentinel Principle Technology | ColonSentry |
| Aristotle | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | StageZero Life Sciences Ltd | Cipher Pharmaceuticals Inc | Avricore Health Inc | Intellipharmaceutics International Inc | Antibe Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | Canada | Canada | Canada | Canada | Canada |
| City | Richmond Hill | Mississauga | Vancouver | Etobicoke | Toronto |
| State/Province | Ontario | Ontario | British Columbia | Ontario | Ontario |
| No. of Employees | 40 | 6 | - | 33 | 11 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James R Howard-Tripp | Chief Executive Officer; Chairman | Executive Board | - | - |
| Rebecca Greco | Head - Investor Relations | Senior Management | - | - |
| Rory Riggs | Director | Non Executive Board | - | - |
| Garth MacRae | Director | Non Executive Board | - | - |
| Harry Glorikian | Director | Non Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer